Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.391 EUR | -2.37% | -1.01% | -15.00% |
May. 07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.00% | 33.67M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Biologics S A : Says Blind Patient Partially Recovers In Phase 1/2 Study of Optogenetic Therapy; Shares Up 7%